Zhang Qiuhang, Ni Zhili, Sun Hetai, Zhang Jianmei
Department of Otorhinolaryngology, Xuanwu Hospital, Capital University of the Medical Sciences, Beijing 100053, China.
Zhonghua Er Bi Yan Hou Ke Za Zhi. 2002 Oct;37(5):363-5.
To report the experience with the perioperative management of endoscopic intrasellar tumor surgery in fifty-two patients with intrasellar tumor who underwent an endoscopic transsphenoidal approach to the sella.
The application of transnasal endoscopic technique to the management of pituitary adenomas in 49 patients, of craniopharyngioma in two patients and of meningeoma in one patient.
Forty-eight of forty-nine cases with pituitary adenomas and two cases with craniopharyngioma were removed completely, the majority of one case with invasive pituitary adenoma and the meningeoma were removed on purpose to decompress. The symptoms of headache, visual desturbance, amenorrhea, galactorrhea ect. were cured or improved. The endocrinological evaluation: the high preoperative prolactin (PRL) and growth hormone (GH) level were decreased to normal values after the operation. Transient and permanent diabetes insipidus occurred in five patients and one patient with pituitary adenomas respectively after the operation, only one case required the treatment. One patient with craniopharyngioma had postoperative epilypsy. Two patients with pituitary adenomas and one patient with craniopharyngioma had recurrence within the one-year (recurrence rate 5.8%) during the follow-up 3-72 months after the surgery. No patient developed a delayed cerebrospinal fluid leak, meningitis, optic nerves injury, internal carotid injury, or other endocrine complications.
This new technique offers simple and rapid access to the sella turcica and also, direct visualization, improves the surgeons ability to resect tumors, it is a safe, minimally invasive and efficient procedure for removing intrasellar tumor.
报告52例鞍内肿瘤患者经鼻内镜经蝶窦入路鞍内肿瘤手术围手术期管理的经验。
49例垂体腺瘤、2例颅咽管瘤和1例脑膜瘤患者采用经鼻内镜技术进行治疗。
49例垂体腺瘤患者中的48例以及2例颅咽管瘤患者肿瘤被完全切除,1例侵袭性垂体腺瘤患者大部分肿瘤被切除,脑膜瘤患者为减压而部分切除。头痛、视力障碍、闭经、溢乳等症状得到治愈或改善。内分泌评估:术前高催乳素(PRL)和生长激素(GH)水平术后降至正常。术后分别有5例垂体腺瘤患者和1例垂体腺瘤患者发生短暂性和永久性尿崩症,仅1例需要治疗。1例颅咽管瘤患者术后发生癫痫。2例垂体腺瘤患者和1例颅咽管瘤患者在术后3至72个月的随访期间1年内复发(复发率5.8%)。无患者发生迟发性脑脊液漏、脑膜炎、视神经损伤、颈内动脉损伤或其他内分泌并发症。
这项新技术提供了简单快速进入蝶鞍的途径,并且直视下提高了外科医生切除肿瘤的能力,是一种安全、微创且有效的切除鞍内肿瘤的方法。